Profile 

Professor Wang Ligen possesses over 40 years of clinical and research experience in oncology. He systematically received top-tier training in both Chinese and Western medicine, establishing profound academic expertise and extensive front-line clinical practice. He completed advanced studies in Radiation Oncology at Harvard Medical School (Boston, USA) and Prince of Wales Hospital (Sydney, Australia). Professor Wang has published over 40 papers in authoritative international and domestic journals, including 5 in SCI-indexed journals, and co-authored 5 medical monographs.

Fluent in English, he regularly conducts bilingual lectures and provides simultaneous interpretation at international conferences.

He Excels in constructing precise radiotherapy protocols for tumors, with significant achievements in personalized radiotherapy and overall quality management in advanced and complex cancer cases.

Expertise

Precision radiotherapy and comprehensive treatment for all types of tumors

Advanced radiotherapy technique:  Proton therapy, IMRT (Intensity-Modulated Radiation Therapy), IGRT (Image-Guided Radiation Therapy), neutron therapy

Cross-border medical consultations and culturally adaptive treatment planning, wit deep understanding of Southeast Asian healthcare preferences and collaborative mechanism  

Education 

1983: Bachelor of Medicine, Department of Military Medicine, Fourt Military Medical University, Xi'an  

1989: Master of Medicine, Fourth Military Medical University, Xi'an  

1993: Doctor of Medicine, Fourth Military Medical University, Xi'an 

1995: Advanced Training in Radiation Oncology, Harvard Medical School, USA  

1997: Among the first batch to obtain the National Large-Scale Medical Equipment (LA) Practice License issued by the Chinese Ministry of Health

1999: Advanced Training in Radiation Oncology, Prince of Wales hospital, Sydney, Australia  

Professional Experience  

Committee Member:  

  • Radiation Oncology Branch, Guangdong Provincial Anticancer Association

  • Radiation Oncology Branch, Guangzhou Anticancer Association

  • Radiation Oncology Society, Guangzhou Medical Association  

  • Extensive experience in medical consultations, lectures, and clinical guidance across Southeast Asia, with deep involvement in international healthcare collaborations  

Academic Achievement 

Co-authored 5 medical monographs on radiation oncology  

Published 40+ research papers in authoritative domestic and international journals, including 5 SCI papers  

Representative publications include: (Specific titles to be added)  

（1）Wang, L.G., Rao, Z.R. and Li, J.S., Prenatal ontogeny of substance P- like immunoreactivity in the trigeminal spinal caudal subnucleus of the human fetus--An immunocytochemical study, Brain Research, 579(1992)157-160

（2）Wang, L.G., Rao, Z.R. and Li, J.S., Prenatal ontogeny of substance P- like immunoreactivity in the parabrachial nucleus of the human fetus—An immunocytochemical study, Brain Research, 590(1993)316-320.

（3）Wang, L.G., Rao, Z.R. and Li, J.S., Prenatal ontogeny of substance P- like immunoreactivity in the nucleus of the tractus solitarius and the dorsal motor nucleus of the vagus nerve of the human fetus- - An immunocytochemical study. Brain Research, 605(1993)9-17

（4）Li Gen Wang, Hui Min Li, Ji Shuo Li, Formalin induced FOS- like immunoreactive neurons in the trigeminal spinal caudal subnucleus project to contralateral parabrachial nucleus in the rat, Brain Research, 649(1994)62-70

（5）Li Gen Wang, Yan Guo, Xiang Zhang, Shao Jun Song, Jie Lai Xia, Feng Yun Fan, Mei Shi, Li Chun Wei,  Brain Metastasis: Experience of the Xi-Jing Hospital， Stereotact Funct Neurosurg 2002;78(2): 70-83

（6）Shen Qian, Ling Ye, Yunhong Tian, Ligen Wang, Zuoping Huang, Feng Li, Bing Hou, Ni Song, Juan Chen, Ying Liu, Xiao Liu and Tao Zhou  Californium-252 (252Cf) neutron brachytherapy combined with external pelvic radiation for cervical cancer: a retrospective clinical study, Chinese Journal of Cancer, 2017; 35(04) 35-43

（7）Junyun Li , Yi Ouyang, Yalan Tao, Ligen Wang, Mingyi Li, Lei Gao,3 Xinping Cao ; Small cell carcinoma of the uterine cervix: a multi-institutional experience. Int J Gynecol Cancer.2020 02 ;30(2) :174-180    DOI：10.1136/ijgc-2019-000612  

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.